Switzerland / Japan / United States / Australia / Israel / /
Event
FDA Phase / Reorganization / /
Facility
University Hospital Cancer Center / University of Zurich / /
IndustryTerm
non-invasive medical device / cancer treatment / /
MedicalCondition
tumor / cancer / primary brain cancer / solid tumors / solid tumor cancer / Newly Diagnosed Glioblastoma / glioblastoma / /
MedicalTreatment
chemotherapy / radiation / /
NaturalFeature
Jersey Isle / /
Organization
Food and Drug Administration / Independent Monitoring Committee / European Union / Society for Neuro-Oncology / University of Zurich / Zurich / Society for NeuroOncology / University Hospital Cancer Center / /
Person
Jersey Isle / Asaf Danziger / Roger Stupp / William Doyle / / /
Position
Principal Investigator / Executive Chairman / Director / Professor and Chairman / Department of Oncology and Director / Chief Executive Officer / physician / /
Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success Data presented today as a late